Anti-SARS CoV-2 IgG in COVID-19 Patients with Hematological Diseases: A Single-center, Retrospective Study in Japan.

MLA

Fujii, Takayuki, et al. “Anti-SARS CoV-2 IgG in COVID-19 Patients with Hematological Diseases: A Single-Center, Retrospective Study in Japan.” Internal Medicine (Tokyo, Japan), vol. 61, no. 11, June 2022, pp. 1681–86. EBSCOhost, https://doi.org/10.2169/internalmedicine.9209-21.

APA

Fujii, T., Hagihara, M., Mitamura, K., Nakashima, S., Ohara, S., Uchida, T., Inoue, M., Okuda, M., Yasuhara, A., Murakami, J., Duong, C., Iwatsuki-Horimoto, K., Yamayoshi, S., & Kawaoka, Y. (2022). Anti-SARS CoV-2 IgG in COVID-19 Patients with Hematological Diseases: A Single-center, Retrospective Study in Japan. Internal Medicine (Tokyo, Japan), 61(11), 1681–1686. https://doi.org/10.2169/internalmedicine.9209-21

Chicago

Fujii, Takayuki, Masao Hagihara, Keiko Mitamura, Shiori Nakashima, Shin Ohara, Tomoyuki Uchida, Morihiro Inoue, et al. 2022. “Anti-SARS CoV-2 IgG in COVID-19 Patients with Hematological Diseases: A Single-Center, Retrospective Study in Japan.” Internal Medicine (Tokyo, Japan) 61 (11): 1681–86. doi:10.2169/internalmedicine.9209-21.